We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688082:SSEACM Research (Shanghai), Inc. Class A Analysis

Data as of 2026-06-18 - not real-time

CN¥367.98

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is riding a strong bullish trend with the MACD line comfortably above its signal line, yet the RSI has surged into overbought territory, signaling a potential short‑term pullback. Volume is on a decreasing trend and the beta is slightly negative, indicating limited market sensitivity, while volatility is near 100% over the past 30 days. Price is perched near its 52‑week high and the computed support sits well below current levels, but the PE ratio is dramatically above the industry average and the DCF fair‑value estimate is a fraction of the market price, painting a picture of extreme overvaluation. The dividend yield is modest and, given the negative free cash flow despite a large cash hoard, the payout appears unsustainable.
Fundamentally, the company posted solid revenue growth of roughly 13% YoY and delivered a 15% full‑year increase in FY2025, with margins remaining healthy around the mid‑40s percent. Recent earnings calls highlighted a new product cycle that accelerated Q1 2026 revenue by over 30% YoY and beat EPS expectations, suggesting a credible growth narrative. However, the combination of a stretched valuation, high volatility, and macro‑level regulatory and geographic risks tempers enthusiasm, urging a measured stance.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI in overbought territory
  • Price near 52‑week high with limited upside
  • Negative free cash flow despite cash reserves

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and expanding margins
  • New product cycle driving earnings beat
  • Valuation remains significantly above fair value

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Long‑term demand for semiconductor equipment in China
  • Strategic product diversification and market positioning
  • Potential upside from continued technology adoption

Key Metrics & Analysis

Financial Health

Revenue Growth13.10%
Profit Margin18.02%
P/E Ratio135.8
ROE11.54%
ROA4.57%
Debt/Equity16.30
P/B Ratio12.9
Op. Cash FlowCN¥1.7M
Free Cash FlowCN¥-3412842240
Industry P/E37.0

Technical Analysis

TrendBullish
RSI78.6
SupportCN¥204.58
ResistanceCN¥383.00
MA 20CN¥267.90
MA 50CN¥205.91
MA 200CN¥178.79
MACDBullish
VolumeDecreasing
Fear & Greed Index88.5

Valuation

Fair ValueCN¥6.12
GradeOvervalued
TypeGrowth
Dividend Yield0.22%

Risk Assessment

Beta-0.34
Volatility98.58%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.